Respiratory Effects of Treatment with a Glucagon-Like Peptide-1 Receptor Agonist in Patients Suffering from Obesity and Chronic Obstructive Pulmonary Disease

PURPOSE: Chronic obstructive pulmonary disease (COPD) affects millions of people worldwide. Obesity is commonly seen concomitantly with COPD. People with COPD have reduced quality of life, reduced physical activity, chronic respiratory symptoms, and may suffer from frequent clinical exacerbations. L...

Descripción completa

Detalles Bibliográficos
Autores principales: Altintas Dogan, Ayse Dudu, Hilberg, Ole, Hess, Søren, Jensen, Torben Tranborg, Bladbjerg, Else-Marie, Juhl, Claus Bogh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882670/
https://www.ncbi.nlm.nih.gov/pubmed/35237033
http://dx.doi.org/10.2147/COPD.S350133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882670/
https://www.ncbi.nlm.nih.gov/pubmed/35237033
http://dx.doi.org/10.2147/COPD.S350133

Ejemplares similares